Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Psychopharmacology and Neuroscience is Scopus-indexed (Q2, CiteScore 5.2), WoS SCIE. Published by Korean College of Neuropsychopharmacology.
Checked against the index lists dated .
ISSN 1738-1088Verify ISSN ↗2093-4327Verify ISSN ↗
Publisher: Korean College of Neuropsychopharmacology
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Psychiatry and Mental Health | 180 / 580 | 69th | Q2 |
| Behavioral Neuroscience | 31 / 93 | 67th | Q2 |
| Pharmacology (medical) | 92 / 278 | 66th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present, best quartile Q2, CiteScore 5.2.
Clinical Psychopharmacology and Neuroscience is Q2 in Psychiatry and Mental Health (rank 180 of 580), Q2 in Behavioral Neuroscience (rank 31 of 93) and Q2 in Pharmacology (medical) (rank 92 of 278), by CiteScore 2025.
Clinical Psychopharmacology and Neuroscience is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.2, which places it in quartile Q2 at the 69th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.976, quartile Q1, with an H-index of 51.
Clinical Psychopharmacology and Neuroscience is published by Korean College of Neuropsychopharmacology. Its print ISSN is 1738-1088 and its online ISSN is 2093-4327.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Clinical Psychopharmacology and Neuroscience has an h-index of 59 and a 2-year mean of 1.87 citations per paper (OpenAlex). Its Scopus CiteScore is 5.2, quartile Q2. On 2-year citations it ranks #226 of 570 Scopus journals in Psychiatry and Mental Health.
Clinical Psychopharmacology and Neuroscience published 74 papers in 2025; its busiest recent year was 2023 with 121. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from South Korea (35.7%), Türkiye (24.7%) and India (9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.